These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16801610)

  • 1. Insulin allergy and immunologic insulin resistance caused by interleukin-6 in a patient with lung cancer.
    Mizuhashi S; Nakamura K; Mori Y; Noda M; Nakanishi K
    Diabetes Care; 2006 Jul; 29(7):1711-2. PubMed ID: 16801610
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surfen allergy causing insulin depot S hypersensitivity].
    Kása M; Borda F
    Orv Hetil; 1990 May; 131(18):965-6, 969. PubMed ID: 2140596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin allergy and insulin resistance.
    Goldfine AB; Kahn CR
    Curr Ther Endocrinol Metab; 1994; 5():461-4. PubMed ID: 7704774
    [No Abstract]   [Full Text] [Related]  

  • 4. Amyopathic dermatomyositis with anti-TIF1 gamma antibodies.
    Schiffmann ML; Warneke VS; Ehrchen J
    J Dtsch Dermatol Ges; 2018 Jan; 16(1):76-78. PubMed ID: 29232033
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin treatment in a patient with Type 2 diabetes and Stiff-person syndrome.
    Weitgasser R; Sommavilla B; Stieglbauer K
    Diabet Med; 2009 Jan; 26(1):111-2. PubMed ID: 19125773
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin allergy and immunologic insulin resistance.
    Davidson JK
    Compr Ther; 1982 Jan; 8(1):46-52. PubMed ID: 7039947
    [No Abstract]   [Full Text] [Related]  

  • 7. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.
    Fareau GG; Maldonado M; Oral E; Balasubramanyam A
    Metabolism; 2007 May; 56(5):670-5. PubMed ID: 17445543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune reactivity during the growth of a murine lung adenocarcinoma: evaluation of paraneoplastic syndrome development.
    Diament MJ; García C; Parma M; Mondelo N; Stillitani I; Klein S
    Oncol Rep; 2001; 8(5):1165-70. PubMed ID: 11496336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin allergy.
    Joshi SR; Shah SN
    J Assoc Physicians India; 1997; Suppl 1():37-40. PubMed ID: 11235633
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of insulin resistance after removal of a parathyroid adenoma in a Type 2 diabetic patient.
    Watanabe Y
    Diabet Med; 2008 Jul; 25(7):883-4. PubMed ID: 18644078
    [No Abstract]   [Full Text] [Related]  

  • 11. Innate immunity, insulin resistance and type 2 diabetes.
    Fernández-Real JM; Pickup JC
    Trends Endocrinol Metab; 2008 Jan; 19(1):10-6. PubMed ID: 18082417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe paraneoplastic gastroparesis associated with anti-Hu antibodies preceding the manifestation of small-cell lung cancer.
    Nguyen-tat M; Pohl J; Günter E; Manner H; Plum N; Pech O; Ell C
    Z Gastroenterol; 2008 Mar; 46(3):274-8. PubMed ID: 18322883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic chorea caused by anti-CRMP5 antibodies associated with small cell lung cancer.
    Jiménez Caballero PE
    Neurologia; 2014 Sep; 29(7):446-7. PubMed ID: 23582747
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
    Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG
    Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three patients with a paraneoplastic neurological syndrome: the significance of paraneoplastic antibodies].
    Smitt PA; Polman SK; de Beukelaar JW; Enting RH; van den Bent MJ; Bromberg JE; Kros JM; Hooijkaas H
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):874-80. PubMed ID: 17472120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.
    Ballani P; Tran MT; Navar MD; Davidson MB
    Diabetes Care; 2006 Nov; 29(11):2504-5. PubMed ID: 17065692
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin allergy: clinical manifestations and management strategies.
    Heinzerling L; Raile K; Rochlitz H; Zuberbier T; Worm M
    Allergy; 2008 Feb; 63(2):148-55. PubMed ID: 18186805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accelerator hypothesis and increasing incidence of type 1 diabetes.
    Fourlanos S; Harrison LC; Colman PG
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):321-5. PubMed ID: 18594271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.